97212 Ventures

Venture Capital New York, United States

Overview

97212 is a seed fund exclusively focused on investing in top early stage Israeli startups committed to building category defining companies in NYC. Our check is just the beginning. We jump in, roll up…

Investment Focus

  • Early-stage Israeli startups building category-defining companies

Portfolio Companies

RitualDigNovoDiaAktivateCopilotKitTrialKitTymelyBetiCauseMatchCeleryCyngGenrateInner BalanceMedidaParaspotPermitRemepyRubatoSymbolicXoltar

Reach 97212 Ventures directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about 97212 Ventures

What sectors does 97212 Ventures invest in?

97212 Ventures invests in Technology, Healthcare, Software, E-commerce and Information Technology, and is based in New York, United States. 97212 Ventures is listed as a venture capital in the ConnectSafely investor database.

What stage does 97212 Ventures invest at?

97212 Ventures backs companies at Seed and Early Stage.

Which regions does 97212 Ventures invest in?

97212 Ventures invests across United States and Israel.

Who are the partners at 97212 Ventures?

Team members listed for 97212 Ventures include Tali Edry (Co-Founder & Advisor) and Eyal Bino (Founding Partner).

What companies has 97212 Ventures invested in?

97212 Ventures's portfolio includes Ritual, Dig, NovoDia, Aktivate, CopilotKit, TrialKit, Tymely and Beti.

How do I contact 97212 Ventures?

97212 Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database